CASE REPORT |
|
Year : 2019 | Volume
: 67
| Issue : 6 | Page : 975-977 |
|
Intravenous tocilizumab in idiopathic pediatric uveitis with refractory cystoid macular edema – A case report
Kalpana Babu1, Bhagya Sudheer1, Anand P Rao2
1 Department of Uveitis and Ocular Inflammation, Vittala International Institute of Ophthalmology and Prabha Eye Clinic and Research Centre, Bengaluru, Karnataka, India 2 Department of Pediatric Rheumatology, Manipal Hospitals, Bengaluru, Karnataka, India
Correspondence Address:
Dr. Kalpana Babu Prabha Eye Clinic and Research Centre, 504, 40th Cross, Jayanagar 8th Block, Bengaluru - 560 070, Karnataka India
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/ijo.IJO_1938_18
|
|
A 13-year-old boy with a 4-year history of idiopathic pediatric uveitis and recurrent uveitic macular edema had failed conventional immunomodulatory therapy and presented to us with a vision of 6/24 [right eye (OD)] and 6/9 [left eye (OS)]. Fluorescein angiography showed diffuse vascular leakage along with cystoid macular edema (CME). Intravenous tocilizumab (10 mg/kg body) was given as 14 injections over 12 months. Repeat fluorescein angiography every 3 months showed a dramatic improvement in the vascular leakage and resolution of CME. At 13 months OF follow-up, vision had improved to 6/9p (OD) and 6/6(OS) with no recurrence of inflammation or CME.
|
|
|
|
[FULL TEXT] [PDF]* |
|
|
|